日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Global cancer statistics for children: Two decades of change and projections to 2050

全球儿童癌症统计数据:二十年来的变化及至2050年的预测

Li, Wangzhong; Huang, Shanzhou; Chen, Qiyue; Wang, Ting; Lu, Guanming; Niu, Xing; Song, Qiong; Xu, Yilin; Mo, Ke; Cui, Chunhui; Zhang, Run; Du, Wei; He, Feiying; Shi, Lei; Lin, Yan; Wei, Qiu; Jiang, Li; Chen, Yongsheng; Song, Baiyang; Zhang, Huijuan; Fu, Zhenli; Liao, Wenjing; Sun, Jiancong; Guan, Wenhui; Zhuang, Weitao; Zhong, Nanshan; Zhou, Chengzhi; Liang, Wenhua; Kang, Min; He, Jianxing

Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study

奥莫替尼联合卡铂-培美曲塞对比奥莫替尼单药治疗EGFR和伴随肿瘤抑制基因的非小细胞肺癌(ACROSS2):一项开放标签、多中心、随机3期研究

Duan, Jian-Chun; Zhong, Jia; Sun, Bo-Yang; Zhao, Wen-Hua; Wu, Lin; Fei, Kai-Lun; Chu, Qian; Guo, Qi-Sen; Song, Qi-Bin; Yu, Yan; Zhu, Da-Xing; Liu, Xin-Yan; Zhao, Jun; Zhan, Zhi-Xiang; Li, Shi; Nie, Lei; Lin, Jie; Peng, Xiao-Dong; Zhong, Dian-Sheng; Zhou, Jin; Li, Li-Hua; Chen, Yun-Fang; Hu, Chen; Mok, Tony; Wang, Zhi-Jie; Wang, Jie

Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: A Randomized Clinical Trial

Tucidinostat Plus R-CHOP vs R-CHOP 治疗 MYC/BCL2 双表达弥漫性大 B 细胞淋巴瘤:一项随机临床试验

Xu, Peng-Peng; Song, Yu-Qin; Shen, Jian-Zhen; Cai, Qing-Qing; Zhou, Hui; Zhang, Li-Ling; Xiang, Ying; Sun, Xiu-Hua; Yang, Wei; Yao, Zhi-Hua; Jing, Hong-Mei; Wen, Shu-Juan; Jin, Jie; Xue, Hong-Wei; Cen, Hong; Ding, Kai-Yang; Jin, Zheng-Ming; Liu, Li-Hong; Xing, Xiao-Jing; Li, Lan-Fang; Hou, Ming; Liu, Lin; Zhang, Ming-Zhi; Li, Wen-Yu; Bai, Ou; Feng, Ru; Zhu, Zun-Min; Wu, Hui-Jing; Su, Li-Ping; Gao, Li; Li, Fei; Huang, Wen-Rong; Liu, Peng; Yan, Xiao-Jing; Zhao, Ying; Su, Hang; Zhao, Xie-Lan; Fu, Rong; Liu, Hong; Shi, Wen-Yu; Li, Hui-Zhi; Chen, Bo; Ning, Zhi-Qiang; Zhu, Jun; Zhao, Wei-Li

Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation: A Randomized Clinical Trial

立体定向放射治疗与避开海马区的全脑放射治疗治疗脑转移瘤:一项随机临床试验

Aizer, Ayal A; Shin, Kee-Young; Catalano, Paul J; Ricca, Ivy; Johnson, Marciana; Benham, Grant; Roper, Kristin; Spicer, Beverly; Mann, Eileen; Nosker, Jennifer; Parsons, Michael W; Mendu, Mallika L; Hepel, Jaroslaw; Chipidza, Fallon; Krishnan, Monica; Shi, Diana D; Lamba, Nayan; Pashtan, Itai; Peng, Luke; Alexander, Brian; Brown, Paul D; Wen, Patrick Y; Haas-Kogan, Daphne A; Rahman, Rifaquat; Tanguturi, Shyam

Correction: Signaling pathways and targeted therapy for pulmonary hypertension

更正:肺动脉高压的信号通路和靶向治疗

Adu-Amankwaah, Joseph; Shi, Yue; Song, Hequn; Ma, Yixuan; Liu, Jia; Wang, Hao; Yuan, Jinxiang; Sun, Kun; Hu, Qinghua; Tan, Rubin

Metabolic dysfunction-associated steatotic liver disease accelerates pancreatic cancer progression and metastasis via the macrophage migration inhibitory factor-CD44 axis

代谢功能障碍相关的脂肪肝疾病通过巨噬细胞迁移抑制因子-CD44轴加速胰腺癌的进展和转移。

Yu, Qian; Song, Hui; Shi, Xiao-Ya; Zhu, Liang; Liang, Yu; Gong, Rui-Ning; Dong, Xiao-Wu; Liu, Shang-Long; Wang, Hai-Zhen; Wang, Ying-Luo; Cui, Jiu-Fa; Yang, Xiao-Nan; Chen, Ying; Gao, Chao; Yang, Zhan; Zhu, Qing-Tian; Li, Chang; Zhang, Huan; Ying, Jie-Er; Zheng, Mei-Fang; Tian, Yan-Tao; Hu, Hai-Tao; Shao, Xin-Xin; Li, Yue; Mo, Ming-Guang; Lu, Yun; Ma, Zheng; Fu, Shun-Li; Niu, Qing-Hui; Liao, Yuan-Yu; Zhao, Chen-Yang; Liu, Xin; Saluja, Ashok K; Wang, Ji-Gang; Li, Xiao-Yu; Guo, Song-Yue; Wang, Wei-Hua; Wang, Song; Liu, Bin; Lu, Guo-Tao; Ren, He

Potent and selective LSD1 inhibitor DC551040 reveals a promising combination therapy for AML with insight into epigenetic dysregulation

强效且选择性的LSD1抑制剂DC551040揭示了一种有前景的AML联合疗法,并有助于深入了解表观遗传失调。

Wang, Jiang; Wang, Hanlin; Du, Runhua; Li, Chunpu; Su, Mingbo; Wang, Shuni; Kan, Weijuan; Liu, Guobin; Zhang, Yu; Hu, Xiaobei; Gao, Feng; Xu, Gaoya; Li, Cong; Zhu, Wei; Ye, Yunfei; Sheng, Li; Shi, Yuqiang; Shao, Yingying; Song, Jiangzhou; Wang, Yuxian; Wang, Bo; Zhou, Yubo; Huang, He; Li, Jia; Liu, Hong

DUSP6 ablation restores CAR T-cell fitness impaired by tumor CD58 loss through invigoration of AP-1 signaling

DUSP6 消融可通过增强 AP-1 信号传导来恢复因肿瘤 CD58 丢失而受损的 CAR T 细胞活性。

Ma, Xinran; Zhang, Yang; Wang, Yao; Han, Fuxin; Lu, Yuting; Tong, Chuan; Guo, Yelei; Wei, Jianshu; Zhu, Qi; Dong, Liang; Cao, Zhi; Meng, Zhenzhen; Shi, Jinhong; Wu, Zhiqiang; Han, Weidong

Lenvatinib plus transarterial chemoembolization and PD-1 inhibitors as conversion therapies for unresectable intermediate-advanced hepatocellular carcinoma: a phase 2 trial and exploratory biomolecular study

乐伐替尼联合经动脉化疗栓塞术和PD-1抑制剂作为不可切除的中晚期肝细胞癌转化疗法:一项II期临床试验和探索性生物分子研究

Zhang, Xiaoyun; Cai, Haozheng; Peng, Wei; Wang, Haiqing; Wu, JiaYi; Zhu, Xinrui; Guo, Weixin; Xie, Fei; Zhang, Yu; Wang, Ming; Yu, Yu; Zhou, Yongjie; Li, Chuan; Shen, Junyi; Liu, Chang; Yang, Yu; Jiang, Xiaozhong; Li, Qiu; Chen, Weixia; Shi, Yujun; Lu, Wusheng; Sun, Xin; Feng, Xielin; Yan, Maolin; Cheng, Shuqun; Wen, Tianfu

Deutenzalutamide, a novel androgen receptor inhibitor, after progression on docetaxel and abiraterone in metastatic castration-resistant prostate cancer: results from the randomized phase III HC-1119-04 trial

在转移性去势抵抗性前列腺癌患者接受多西他赛和阿比特龙治疗后出现疾病进展的情况下,新型雄激素受体抑制剂氘代沙鲁胺的疗效:来自随机 III 期 HC-1119-04 试验的结果

Wu, Junlong; Li, Xinghai; Gu, Chengyuan; Hua, Lixin; Liu, Ranlu; Li, Jun; Qiu, Mingxing; Guo, Jianming; Dong, Haiying; Ji, Zhigang; Xie, Liping; Zhu, Shaoxing; Zhang, Xuhui; Chen, Peng; Jiang, Shusuan; Sun, Zhongquan; Xu, Danfeng; Chen, Hui; Shi, Benkang; Wang, Yujie; Pu, Jinxian; Perabo, Frank; Chen, Yuanwei; Ye, Dingwei